A COVID-19 Antibody Cocktail Made Possible By 15,000 New Yorkers

Sorrento Therapeutics - 1 minute read

  • Sorrento partners with New York City’s Mount Sinai Health System to develop an antibody cocktail to potentially treat or prevent COVID-19
  • Human trials expected in the third quarter
  • Using antibodies Mount Sinai obtained from nearly 15,000 COVID-19 patients

“Each dose of the drug candidate would deliver a cocktail of three antibodies, which is expected to provide protection against the virus for up to two months”

Henry Ji, CEO – Sorrento Therapeutics

11 months ago from Sorrento Therapeutics's press release via